Literature DB >> 11192989

An attempt to measure burden of disease using disability adjusted life years for Sri Lanka.

K Wijewardene1, M Spohr.   

Abstract

INTRODUCTION: Disability adjusted life years (DALY) is a measure of burden of disease (BOD) that assesses the years of healthy life lost due to disease or illness.
OBJECTIVE: The main objective of the study was to develop a draft measure of the BOD in Sri Lanka, using DALY.
METHODS: Computation was done for 100 disease categories identified to reflect the disease pattern in Sri Lanka. Factors that were considered for the calculation of DALY were incidence, degree of disability, duration of the illness and age of onset.
RESULTS: Injuries, ischaemic heart disease, asthma, disease of the pulmonary circulation and burns contribute to 55% of BOD in Sri Lanka.
CONCLUSION: The highest burden was due to non-communicable diseases, as their duration and degree of disability are high. Diseases such as malaria, which are short term illnesses with low disability, although affecting large numbers, did not give a high value for DALY.

Entities:  

Mesh:

Year:  2000        PMID: 11192989     DOI: 10.4038/cmj.v45i3.8110

Source DB:  PubMed          Journal:  Ceylon Med J        ISSN: 0009-0875


  2 in total

1.  Social, cultural and economical determinants of diabetes mellitus in Kalutara district, Sri Lanka: a cross sectional descriptive study.

Authors:  Ambepitiyawaduge Pubudu De Silva; Sudirikku Hennadige Padmal De Silva; Isurujith Kongala Liyanage; Lalini Chandika Rajapakse; Kosala Saroj Amarasiri Jayasinghe; Prasad Katulanda; Chandrika Neelakanthi Wijeratne; Sumedha Wijeratne
Journal:  Int J Equity Health       Date:  2012-12-13

2.  Epidemiology of chronic kidney disease, with special emphasis on chronic kidney disease of uncertain etiology, in the north central region of Sri Lanka.

Authors:  Kithsiri Bandara Jayasekara; Dhammika Menike Dissanayake; Ramiah Sivakanesan; Asanga Ranasinghe; Ranawaka Hewage Karunarathna; Gardiye Waligamage Gamini Priyantha Kumara
Journal:  J Epidemiol       Date:  2015-03-17       Impact factor: 3.211

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.